Your session is about to expire
← Back to Search
Sedentary Behavior Interruption Strategies for Sedentary Lifestyle
N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial will test the effects of 3 different ways of interrupting sitting on biomarkers of healthy aging and physical functioning in 405 overweight, postmenopausal women.
Who is the study for?
This trial is for overweight, postmenopausal women aged 55 and above who are medically stable. Participants should be able to stand and walk without a high risk of falling, have a BMI between 25-45, sit for more than 7 hours daily, do less than 70 sit-to-stand transitions per day, and must be fluent in English.Check my eligibility
What is being tested?
The study tests if health coaching or tools that prompt standing can interrupt sedentary behavior in older women. It's part of the STAR program aiming to understand how breaking up sitting time affects healthy aging. Women will randomly receive one of these interventions.See study design
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication, side effects may include muscle soreness or fatigue from increased activity. However, specific side effects will depend on individual experiences with changing sedentary habits.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glucose Regulation
Secondary outcome measures
Functional Changes
Mitochondrial Function
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Sit-to-Stand TransitionExperimental Treatment3 Interventions
Participants in the Sit-to-Stand Transition condition will receive an intervention aimed at increasing the daily number of brief sit-to-stand transitions. This group will receive five in-person health coaching sessions and two phone counseling sessions.
Group II: Reduce SittingExperimental Treatment3 Interventions
Participants in the Reduce Sitting condition will receive an intervention aimed at reducing daily sitting time. This group will receive five in-person health coaching sessions and two phone counseling sessions.
Group III: Health Living Attention ControlActive Control1 Intervention
Participants in the attention control condition will receive a healthy aging educational intervention. This group will receive one in-person health coaching sessions and 6 phone counseling sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Coaching
2018
N/A
~1880
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,123 Previous Clinical Trials
1,552,434 Total Patients Enrolled
11 Trials studying Sedentary Lifestyle
1,721 Patients Enrolled for Sedentary Lifestyle
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have physical limitations that would prevent you from completing any part of the study requirements.You started menstruating within the last year.You are unable to complete a simple physical performance test.Your body mass index (BMI) is between 25 and 45.You currently have cancer that is growing or spreading.Your body weight is either too low or too high according to your height.You are a woman.People of any race or ethnicity can participate.You are male.You are able to walk on your own without assistance.
Research Study Groups:
This trial has the following groups:- Group 1: Health Living Attention Control
- Group 2: Reduce Sitting
- Group 3: Sit-to-Stand Transition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any participants currently being recruited for this experiment?
"Evidently, the information on clinicaltrials.gov reveals that this particular study is no longer recruiting participants as it was last updated on October 13th 2022. Nevertheless, there are 18 other trials actively seeking candidates at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger